The Chief Minister of Telangana delivered a momentous address during the inauguration of the Healthcare and Life Sciences Bio Asia 2024, where he unveiled ambitious plans for the expansion of Hyderabad Genome Valley into its second phase. This expansion initiative signifies a significant stride towards solidifying Hyderabad’s stature as a global epicenter for biosciences and healthcare innovation.
In his comprehensive address, the Chief Minister delineated the expansive vision for the future of Genome Valley, earmarking a substantial 300 acres of prime real estate and allocating a noteworthy investment of Rs. 2000 crores. Furthermore, he shed light on the ongoing initiative to establish ten state-of-the-art pharma villages, each boasting a staggering investment of one lakh crores. Strategically situated across Vikarabad, Medak, and Nalgonda districts, these pharma villages capitalize on the burgeoning greenfield pharma sectors and enjoy convenient proximity to the Hyderabad International Airport, thereby presenting an irresistible proposition for global entrepreneurs seeking to capitalize on Hyderabad’s burgeoning bioscience ecosystem. Moreover, the Chief Minister underscored the pivotal role of the Bio Asia conference, particularly in the wake of the formidable global health challenges exacerbated by the relentless onslaught of the Covid-19 pandemic. He underscored Hyderabad’s indispensable role as a global hub for bioscience and vaccine production, revealing the staggering statistic that one in every three vaccines utilized worldwide is manufactured within the confines of Hyderabad itself. In conclusion, the Chief Minister reiterated his unwavering commitment to nurturing Hyderabad’s growth trajectory across a diverse array of sectors, ranging from IT-software and research to burgeoning start-up ventures and cutting-edge bioscience initiatives. He affirmed the government’s steadfast dedication to fostering an environment conducive to innovation and collaboration, thereby propelling Hyderabad to the forefront of the global bioscience landscape.
